Title : Functional characterization of a nucleoside-derived drug transporter variant (hCNT3C602R) showing altered sodium-binding capacity.

Pub. Date : 2008 Feb

PMID : 17993510






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The resulting hCNT3(C602R) protein has the same selectivity and affinity for natural nucleosides and nucleoside-derived drugs as hCNT3 but much lower concentrative capacity. Nucleosides solute carrier family 28 member 3 Homo sapiens
2 The resulting hCNT3(C602R) protein has the same selectivity and affinity for natural nucleosides and nucleoside-derived drugs as hCNT3 but much lower concentrative capacity. Nucleosides solute carrier family 28 member 3 Homo sapiens
3 The sodium activation kinetic analysis of both transporters revealed a variation in the affinity for sodium and a shift in the Hill coefficient that could be consistent with a stoichiometry of 2:1 and 1:1 sodium/nucleoside, for hCNT3 and hCNT3(C602R), respectively. Nucleosides solute carrier family 28 member 3 Homo sapiens
4 The sodium activation kinetic analysis of both transporters revealed a variation in the affinity for sodium and a shift in the Hill coefficient that could be consistent with a stoichiometry of 2:1 and 1:1 sodium/nucleoside, for hCNT3 and hCNT3(C602R), respectively. Nucleosides solute carrier family 28 member 3 Homo sapiens
5 Individuals with the hCNT3(C602R) variant might show a lower nucleoside and nucleoside analog concentrative capacity, which could be clinically relevant. Nucleosides solute carrier family 28 member 3 Homo sapiens
6 Individuals with the hCNT3(C602R) variant might show a lower nucleoside and nucleoside analog concentrative capacity, which could be clinically relevant. Nucleosides solute carrier family 28 member 3 Homo sapiens